EyeGene Inc. (KOSDAQ:185490)

EyeGene Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	4,139	10,194	1,425	5,496	2,046	2,649
Short-Term Investments	34,535	33,300	31,122	49,872	59,080	72,680
Trading Asset Securities	-	2,002	-	-	5,329	10,027
Cash & Short-Term Investments	38,675	45,497	32,547	55,368	66,455	85,357
Cash Growth	29.98%	39.79%	-41.22%	-16.68%	-22.14%	163.86%
Accounts Receivable	1,507	772.12	1,415	468.06	898.07	731.32
Other Receivables	-	167.4	312.04	428.64	486.97	296.1
Receivables	1,507	939.53	1,727	896.7	1,385	1,027
Inventory	728.38	750.72	584.99	55.21	498.01	774.4
Prepaid Expenses	-	307.95	149.19	240.5	-	-
Other Current Assets	247.48	141.88	289.3	317.01	492.77	1,485
Total Current Assets	41,157	47,637	35,298	56,877	68,830	88,644
Property, Plant & Equipment	5,087	5,992	9,315	9,851	5,742	5,864
Long-Term Investments	8,513	7,746	14,159	9,337	3,807	4,076
Other Intangible Assets	2,887	2,901	4,281	982.61	844.1	761.27
Other Long-Term Assets	3,782	3,750	2,150	1,055	1,158	5,646
Total Assets	61,428	68,051	65,306	78,103	80,381	104,991

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1,570	1,301	1,680	470.69	863.84	1,894
Accrued Expenses	-	302.65	252.29	341.29	343.29	361.43
Short-Term Debt	-	-	1,773	1,498	1,392	2,995
Current Portion of Leases	177.23	168.61	179.6	314.49	392.85	272.63
Current Unearned Revenue	-	1.33	0.64	3.33	3.2	3.16
Other Current Liabilities	6,520	6,318	5,534	5,634	1,924	4,083
Total Current Liabilities	8,268	8,092	9,419	8,262	4,920	9,609
Long-Term Leases	333.19	391.62	487.56	338.43	611.41	676.06
Pension & Post-Retirement Benefits	3,204	2,915	2,546	3,485	4,613	4,055
Long-Term Deferred Tax Liabilities	-	-	-	-	-	1,168
Other Long-Term Liabilities	309.83	490.9	437.83	626.99	1,281	513.64
Total Liabilities	12,114	11,889	12,891	12,713	11,426	16,022

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	21,615	21,615	13,515	13,515	10,739	10,705
Additional Paid-In Capital	202,340	202,340	188,325	188,329	176,131	176,277
Retained Earnings	-184,667	-177,465	-161,740	-149,862	-129,722	-103,829
Comprehensive Income & Other	10,985	10,637	10,221	11,248	9,580	5,816
Total Common Equity	50,273	57,127	50,321	63,230	66,728	88,969
Minority Interest	-3,058	-2,875	513.52	1,104	2,228	-
Shareholders' Equity	49,313	56,162	52,415	65,390	68,956	88,969
Total Liabilities & Equity	61,428	68,051	65,306	78,103	80,381	104,991

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	510.42	560.24	2,441	2,151	2,397	3,943
Net Cash (Debt)	38,165	44,936	30,107	53,217	64,058	81,413
Net Cash Growth	40.37%	49.26%	-43.43%	-16.92%	-21.32%	434.64%
Net Cash Per Share	1058.71	1607.06	1114.59	2458.55	2987.22	4298.37
Filing Date Shares Outstanding	43.22	43.22	27.03	27.03	21.48	21.41
Total Common Shares Outstanding	43.22	43.22	27.03	27.03	21.48	21.41
Working Capital	32,890	39,545	25,878	48,615	63,911	79,034
Book Value Per Share	1163.11	1321.69	1861.69	2339.28	3106.77	4155.60
Tangible Book Value	47,386	54,226	46,040	62,248	65,884	88,208
Tangible Book Value Per Share	1096.31	1254.56	1703.31	2302.93	3067.47	4120.04
Machinery	-	10,803	13,374	13,392	7,251	6,154
Construction In Progress	-	-	-	-	102.83	613.25

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 22, 2026

Data Sources Report a data error